The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of aerosol gemcitabine for the treatment of patients with solid tumors and lung metastases.
 
Nancy Beatriz Gordon
No Relationships to Disclose
 
Eugenie Kleinerman
No Relationships to Disclose
 
Ajay Sheshadri
No Relationships to Disclose
 
David Blanco
No Relationships to Disclose
 
Sireesha Yedururi
No Relationships to Disclose
 
Ajaykumar Morani
No Relationships to Disclose
 
Jonathan Benjamin Gill
Consulting or Advisory Role - Celgene (I); Legend Biotech (I); Puma Biotechnology (I)
 
Douglas James Harrison
No Relationships to Disclose
 
Cynthia E. Herzog
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Array BioPharma; Genentech; Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
J Andrew Livingston
No Relationships to Disclose
 
Robert S. Benjamin
Stock and Other Ownership Interests - Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Merck Serono (I); Pfizer (I)
 
Richard Greg Gorlick
Research Funding - Eisai (Inst)
 
Maria E Mireles
No Relationships to Disclose
 
Jitesh D Kawedia
No Relationships to Disclose
 
Najat C. Daw
Consulting or Advisory Role - Bayer; Incyte